RSM logo
Journal of Integrated Care Pathways

Home Current issue Browse archive Alerts About the journal Feedback
 
J Integr Care Pathw 2008;12:5-9
doi:10.1258/jicp.2008.008001
© 2008 Royal Society of Medicine Press

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Levelt, E.
Right arrow Articles by Yadegarfar, G.
Right arrow Search for Related Content
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Original articles

Integrated care pathway for acute coronary syndromes: does it help?

Eylem Levelt * , Barnaby Thwaites {dagger} and Ghasem Yadegarfar {ddagger}

* Royal Cornwall Hospital, Truro, UK; {dagger} Royal Hampshire County Hospital, Winchester, UK; {ddagger} Biostatistics & Epidemiology Department, School of Health Sciences, Isfahan University of Medical Sciences, Isfahan, Iran

Correspondence to: EL Email: eylem{at}doctors.org.uk

The use of integrated care pathways (ICPs) to enhance quality and consistency of patient care has increased in the last decade. In two closely related studies, we first assessed the benefit of a new ICP for acute coronary syndrome in our district hospital, and secondly assessed the impact of ICPs in UK coronary care units, correlating with data from the Myocardial Infarction National Audit Programme, MINAP. The new local ICP produced statistically improved admission medication, with the chance of correctly prescribing aspirin increasing by 63% (P < 0.002), and borderline increase for clopidogrel of 28% (P > 0.10), and enoxaparin of 21% (P > 0.06), in a completed audit cycle study totalling 100 patients. A national telephone survey showed that of 210 UK coronary care units, only 40% had an ICP in place, and this made no difference to either door-to-needle time for thrombolysis or to rates of discharge medication with aspirin, beta-blockers or statins.While these results fail to raise enthusiasm for implementing an ICP, other potential benefits of their use may be important such as optimizing data collection, improving consistency of care and unifying the different clinical teams in planning the care of the patient.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




History of the London Clinic